Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin

Circulation

Volumn 99, Issue 4, 1999, Pages 475-481

  Guethlin, Martin ^a   Kasel, Albert Markus ^a   Coppenrath, Klaus ^a   Ziegler, Sibylle ^a   Delius, Wolfram ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenosine; Blood flow; Fluvastatin; Lipids; PET

Indexed keywords

ADENOSINE; ANTILIPEMIC AGENT; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG EFFECT; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VASODILATATION;

EID: 0033514258     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.4.475     Document Type: Article

References (29)

1. Scandinavian Simvastatin Study Group. Randomized trial of cholesterol lowering therapy in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-1389.
2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med I995;333: 1301-1307.
3. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol eeh.NEnglJMed. 1996;335:IOOI-I009.
4. Waters D, Pedersen TR. Review of cholesterol-lowering therapy: coronary angiographie and events trials. Am J Med. 1996;101:34S-39S.
5. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332: 488-493.
6. Treasure CB, Klein JL, Weintraub WS, Talley DJ, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332:481-487.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993:362:801-809.
8. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole on patients with coronary artery disease. Circulation. 1994;89:1530-1538.
9. Hutchins CD, Schwaiger M, Rosenspire KC, Kri'vokapich J, Scheiben H, Kühl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
10. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-817.
11. Muzik O, Beanlands R, Wolfe E, Hutchins G, Schwaiger M. Automated region definition for cardiac nitrogen-13-ammonia PET imasins. J Nucl Med. 1993;34:336-344.
12. Laubenbachcr C, Rothley J, Silomer J, Beanlands R, Sawada S, Sutor R, Muller D, Schwaiger M. An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med. 1993;34:969-978.
13. Beanlands RSB, Muzik O, Melon P, Sutor R, Sawada S, Muller D, Bondie D, Hutchins CD, Schwaiger M. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. J Am Coll Cardiol. 1995:26:1465-1475.
14. Campeau L. Grading of angina pectoris.. Circulation. 1976:54:522. Letter.
15. Reiber JHC. Assessment of dimension and image quality of coronary contrast catheter from cine angiograms. Caihet Canliovasc Diagn. 1985;! 1:521-531.
16. Demer LL, Could KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RV, Nishikawa A, Merhige ME. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients. Circulation. 1989;79:825-835.
17. Uren NG, Melin JA, DeBruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 1994;330:1782-I788.
18. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Scheiben HR. Relation among stenosis severity, myocardial blood flow and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-195I.
19. Gould KL. Identifying and measuring severity of coronary artery stenosis: quantitative coronary arteriography and positron emission tomography.. Circulation. 1988;78:237-245.
20. Czemin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Scheiben HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993:88:62-69.
21. Uren NO, Camici P, Melin JA, Bole A, deBruyne B, Radavan J, Olivotto l, Rosen SD, Impallomeni M, Wijns W. Effect of aging on myocardial perfusion reserve. J Nucl Med. 1995;36:2032-2036.
22. Benzuly KH, Padgett RC, Kaul S, Piegors DJ. Armstrong LM, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation. 1994;89:1810-1818.
23. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dcpendent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:180S-1811.
24. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-cocnzyme A reductase inhibitor, improves endothelial dysfunction within 1 month. Circulation. 1997;95:1126-1131.
25. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolcmic patients off and on lipid-lowering medication. Lancet. 1995;346:467-471.
26. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation. 1997;95:76-82.
27. Czernin J, Barnard RJ, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, Phelps ME, Scheiben HR. Effects of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 1995;92:197-2(W.
28. Verbeuren TJ, Jordaens FH, Zonekeyn LL, Van Hove CE. Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in rabbits, I: endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Ci re Res. 19S6;58:552-562.
29. Nitenberg A, Antoni I. Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results. Eur Heart J. 1995;16(suppl I):7-21.